Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

09 oct. 2025 23h00 HE | Source: Oralift

Oralift Neuro: A New Concept to Support Brain Recovery in Contact Sports

Oralift Neuro explores how gentle neuromuscular stimulation could aid brain recovery after head impacts in rugby and American football.
23 févr. 2024 07h00 HE | Source: Biogen Inc.

Biogen’s QALSODY® (tofersen), the First Therapy to Treat Rare, Genetic Form of ALS, Received Positive Opinion from CHMP

SOD1-ALS is a devastating, uniformly fatal, and ultra-rare genetic form of ALS affecting less than 1,000 people in Europe1With QALSODY, Biogen has advanced the role of neurofilament in the development...
06 déc. 2023 02h00 HE | Source: LifeArc

LifeArc announces £5 million drug repurposing programme for motor neuron disease

MEDIA RELEASE LifeArc announces £5 million drug repurposing programme for motor neuron disease LifeArc is launching new £5m programme to help find new treatments for motor neuron disease (MND).The...